Tag: LTUS

Lotus Pharmaceuticals, Inc. (LTUS) Receives Phase I Approval for Asthma DrugInternational Business TimesLotus Pharmaceuticals, Inc. said that research conducted by a third party indicated that the Asthma market in China is approximately $300 million annually, …Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical …PR Newswire (press release)all 12 news articles » View full post […]